A unique opportunity to learn from the best in a program that stands out for the quality of its content and its innovative teaching methodology"

Over the last few decades, the number of people in need of Psychotropic medication has increased. These figures are of concern to specialists, not only because of the serious problem they represent, but also because these specialists are the ones responsible for the correct diagnosis and treatment of the diseases that each individual is suffering from. This program analyzes disorders such as psychosis, dementia, eating disorders and even insomnia.

This Professional master’s degree also covers the main current topics in Psychopharmacology in the medical field, such as pharmacological intervention in anxiety disorders and stress, or painkillers.  It is not, therefore, just another diploma for your professional profile, but a real learning tool to help you approach the topics of the specialty in a modern, objective and discerning way.

Additionally, as it is an online program, students are not restricted by fixed schedules or the need to move to another physical location to attend classes. You can access the content at any time of day through a device with an internet connection. This way, you will easily be able to balance your work and personal life with your academic life.  

TECH offers you a 100% online study opportunity that is as complete as possible and always linked to current events"

This Professional master’s degree in Psychopharmacology contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in Psychopharmacology
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This degree is the best investment you can make in selecting a refresher program to update your knowledge of psychopharmaceuticals"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year. For this purpose, the student will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will delve into the different manifestations of anxiety, stress and depression, and the most appropriate psychotropic drugs for each case"

Broaden your knowledge thanks to the best teaching material with real clinical cases"

The structure of this program’s content has been designed by a team of professionals from the best educational centers and universities in the field, who are aware of the current relevance of innovative teaching, and who are committed to quality learning through new educational technologies.

A comprehensive teaching program, structured in well-developed teaching units, oriented towards efficient and swift learning that is compatible with your personal and professional life”

Module 1. Pharmacology and its Objectives in the Psychological Therapeutic Process

1.1. Anthropological, Historical, Sociological and Psychological Perspective on the Use of Medication
1.2. Objectives of Pharmacology
1.3. Concept of Pharmacology
1.4. Therapeutic Pharmacology
1.5. Pharmacodynamics
1.6. Pharmacokinetics
1.7. Plasma Level Curve
1.8. Toxicology
1.9. Social Aspects of Medication
1.10. Medication Intervention Process
1.11. Information Form for the Patient to Receive Psychopharmacological Treatment
1.12. Signs and Symptoms. Illnesses and Syndromes

Module 2. Anamnesis and the Decision to Choose the Appropriate Medication

2.1. Active Interview (CHSV)
2.2. Information Theory
2.3. Communication Channels
2.4. Communication System
2.5. Axioms of the Interview
2.6. It is Impossible Not To Communicate
2.7. Content and Relationship
2.8. Affective Value
2.9. Digital and Analog Communication
2.10. Symmetric and Asymmetric
2.11. Exploring Communication
2.12. Verbal Communication
2.13. Non-Verbal Communication
2.14. Double Bond
2.15. Psychopathology of Communication
2.16. A Gesture is Worth a Thousand Words
2.17. Medical History
2.18. General Structure of the Mental Examination
2.19. Semiology
2.20. Epistemology of Diagnosis
2.21. Some Special Types of Clinical Interviews

Module 3. Classification of Psychotropic Medication

3.1. Neurophysiological Foundations of Mental Illness and its Treatment
3.2. Antipsychotics and Neuroleptics
3.3. Anxiolytics and Sedatives
3.4. Antidepressants
3.5. Antimanic or Euthymic Medication
3.6. Antiseizure Medications
3.7. Medication for Agitation
3.8. Pharmacotherapy for Confusion
3.9. Drugs for Dementia
3.10. Medication Against Deficiencies

Module 4. Pharmacological Intervention for Anxiety and Stress Disorders and Stress

4.1. Anxiety or Panic Disorder
4.2. Agoraphobia
4.3. Social Phobia
4.4. Specific Phobias
4.5. Generalized Anxiety Disorder
4.6. Obsessive Compulsive Disorder and Related Disorders
4.7. Separation Anxiety Disorder
4.8. Adaptive Disorder
4.9. Dissociative Disorders
4.10. Somatic Symptom Disorders and Associated Conditions
4.11. Trauma and Stress-Related Disorders
4.12. Post-Traumatic Stress
4.13. Disinhibited Social Relationship Disorder

Module 5. Intervention with Psychotropic Drugs in Depression, Eating Disorders, and Sleep Disorders

5.1. Disruptive Mood Dysregulation Disorder
5.2. Major Depressive Disorder
5.3. Persistent Depressive Disorder (Dysthymia)
5.4. Premenstrual Dysphoric Disorder
5.5. Substance-Induced Depressive Disorder
5.6. Pica
5.7. Rumination Disorder
5.8. Food Avoidance Disorder
5.9. Anorexia Nervosa
5.10. Bulimia Nervosa
5.11. Binge Eating Disorder
5.12. Insomnia
5.13. Hypersomnia
5.14. Narcolepsy
5.15. Obstructive Sleep Apnea
5.16. Sleep-Related Hypoventilation
5.17. Non-REM Sleep Awakening Disorders
5.18. Nightmare Disorder
5.19. Restless Leg Syndrome

Module 6. Pharmacotherapy of Psychosis and Dementias

6.1. Schizophrenia and Schizophreniform Psychoses
6.2. Delusional Disorder
6.3. Brief Psychotic Disorder
6.4. Substance-Induced Psychotic Disorder
6.5. Catatonia
6.6. Bipolar Disorder
6.7. Cyclothymic Disorder
6.8. Delirium
6.9. Alzheimer’s Disease
6.10. Frontotemporal Lobe Degeneration
6.11. Dementia due to Brain Trauma
6.12. Vascular Dementia
6.13. Dementia due to Parkinson's Disease
6.14. Dementia due to Huntington's Disease
6.15. Personality Disorders
6.16. Iatrogenesis

Module 7. Medication Used in the Pain Unit

7.1. Medical History of the Patient in Pain
7.2. Psychosocial Approach Chronic Pain
7.3. Patient-Controlled Analgesia (PCA)
7.4. Pain in Polytrauma Patients
7.5. Pain in Severe Burns
7.6. Headaches and Facial Pain
7.7. Treatment of Neuralgia
7.8. Treatment of Oncological Pain
7.9. Pain and Terminal Sedation
7.10. Fibromyalgia

A unique, key and decisive educational experience to boost your professional development”